Abstract
Background In early 2020, following the start of the coronavirus disease 2019 (COVID-19) pandemic, institutions of higher education (IHEs) across the United States rapidly pivoted to distance learning to reduce risk of on-campus virus transmission.
Objective To explore IHE use of nonpharmaceutical interventions (NPIs) during the subsequent pandemic-affected academic year 2020–2021.
Design Cross-sectional study of data collected January – June 2021. Setting: US four-year, undergraduate IHEs.
Patients (or Participants) All public (n=547) and a stratified random sample of private (n=300) IHEs.
Measurements From IHE websites, we documented NPIs, including changes to the calendar, learning environment, housing, common areas, and dining; COVID-19 testing; and facemask protocols, and performed weighted analysis to assess congruence with the US Centers for Disease Control and Prevention (CDC) guidance for IHEs. We used weighted multivariable linear regression to explore the association between IHE characteristics and the summated number of implemented NPIs.
Results Overall, 20% of IHEs implemented all surveyed CDC-recommended NPIs. The most frequently utilized were learning environment changes (91%), practiced as one or more of the following: distance or hybrid learning opportunities (98%), 6-feet spacing (60%), and reduced class sizes (51%). Additionally, 88% of IHEs specified facemask protocols, 78% physically modified common areas, and 67% offered COVID-19 testing. Among the 33% of IHEs offering ≥50% of courses in person, having <1,000 students was associated with having implemented fewer NPIs than IHEs with ≥1,000 students.
Limitations Data collected from publicly available sources may introduce observation biases but allow for large sample size.
Conclusion Only 1 in 5 IHEs implemented all surveyed CDC recommendations, while a majority implemented a subset. IHE size and location were associated with degree of NPI implementation. Additional research is needed to assess adherence to NPI implementation in IHE settings.
Funding Source United States Centers for Disease Control and Prevention
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the United States Centers for Disease Control and Prevention (http://www.cdc.gov/). The co-authors are or were employees (NZ FA AU) or an ORISE fellow (SM) of the US CDC at the time of the study. The funder of author SM (Oak Ridge Institute for Science and Education) provides support in the form of a stipend, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the Author Contributions section.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention. During the study period, SM was a fellow appointed through the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the US Centers for Disease Control and Prevention.
Financial support: This study was supported by the United States Centers for Disease Control and Prevention (http://www.cdc.gov/). The co-authors are or were employees (NZ FA AU) or an ORISE fellow (SM) of the US CDC at the time of the study. The funder of author SM (Oak Ridge Institute for Science and Education) provides support in the form of a stipend, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the ‘Author Contributions’ section.
IRB Approval: The project underwent ethical review at the Centers for Disease Control and Prevention’s Human Research Protections Office and was determined not to involve human subjects; it was therefore not subject to institutional review board review requirements.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
